“Identification of Earlier Stage Autoimmune Type 1 Diabetes Using Machine Learning Algorithms” study featured at American Diabetes Association’s 85th Scientific Sessions
Waltham, MA, July 17, 2025 – Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industry, presented results from a new study demonstrating the potential of an artificial intelligence and machine learning (AIML) model to detect type 1 diabetes (T1D) at least one year before a patient’s clinical diagnosis. Leveraging Trinity’s leading-edge AI capabilities…
Read Now
New Technical White Paper Highlights Five Essential Questions for Life Sciences Companies as Generative AI Grows and Evolves
Waltham, MA, June 4, 2025 — Trinity Life Sciences, the leader in advisory, insights and analytics for the life sciences industries, discusses the journey to achieving successful transformation with generative AI (GenAI) in a new white paper, entitled Technology with a Point of View: Encoding Life Sciences Expertise with AI.
GenAI is a technological disruption with significant potential to revolutionize biopharmaceutical commercialization…
Read Now
Strategic Collaboration Between Ontada and Trinity Leverages Advanced Analytics and Community Oncology Insights to Improve Provider Outreach and Patient Care
Waltham, MA, May 29, 2025 — Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industries, announces a strategic collaboration with Ontada, a McKesson business and leader in community oncology real-world data, clinical education and point-of-care technologies. This relationship will provide life sciences companies with real-time, actionable intelligence and critical insights to drive strategic decisions…
Read Now
AbbVie, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Among Honorees for Exceptional Performance in Pharmaceutical Operations, Recognized as Industry Leaders by TGaS Division
Waltham, MA, May 6, 2025 – Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces the winners of the TGaS Advisors Best of Benchmark (BoBs) Awards. The Awards, which are given annually for operational excellence within the pharmaceutical industry, were presented to teams at AbbVie, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson…
Read Now
“Predicting Winners: AI-Powered Portfolio Management” White Paper Now Available
Trinity’s AI algorithm accurately predicts outcomes for more than 90% of U.S. drug launches. As shown in this chart, this accuracy far exceeds the consensus of Wall Street analysts.
Waltham, MA, April 16, 2025 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduced its artificial intelligence (AI) algorithm which accurately predicted revenue outcomes for over 90% of U.S. drug launches, far exceeding the…
Read Now
Trinity Life Sciences Introduces a Dedicated Value Center of Excellence, Delivering A Uniquely Integrated Combination of Market Access and HEOR Expertise
Waltham, MA, April 15, 2025 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces a dedicated Value Center of Excellence (COE) that provides end-to-end partnership along the value journey to Market Access and Health Economics and Outcomes Research (HEOR) teams, from strategy to communication. The COE approaches U.S. and global value…
Read Now
Enhanced HTA Vision Offering from Trinity Life Sciences Provides Efficiencies with a Layer of Expert Insights
Waltham, MA, March 11, 2025 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, today announces an enhancement to its HTA Vision offering that swiftly extracts relevant information from health technology assessments (HTAs) and Trinity expert analyses, streamlining the information-gathering process within any therapeutic area or drug class. By not only locating but also summarizing key information…
Read Now
Focused Center of Excellence from Trinity Life Sciences Uses Quantitative and Qualitative Information to Assess Pre- and Post-Launch Educational and Marketing Materials
Waltham, MA, December 16, 2024 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduces a focused Marketing Communications Insights (MarCom Insights) Center of Excellence (COE) that assesses pre- and post-launch educational and marketing materials focused on healthcare professionals (HCPs) and patients. The COE leverages behavioral science and AI with an…
Read Now
Waltham, MA, December 11, 2024 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, looks at AI from the lens of business value, solving business problems with integrated intelligence. Trinity’s digital products and AI solutions are tightly integrated across the scope of the Company’s offerings, providing insights to commercial and medical leaders and orchestrating customer engagement. To lead these important initiatives, Trinity has appointed Jonathan Jenkins, formerly of McKinsey & Company’s QuantumBlack, to…
Read Now
Waltham, MA, December 5, 2024 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, released its fourth annual TGaS Digital Marketing Competency Report assessing the digital marketing presence for patients across 150+ biopharma brands. The study evaluates the brands across five categories and more than 100 characteristics to establish a brand digital competency ranking.
Brands that topped the 2024 Digital Marketing Competency Report’s list include:
Pfizer’s Nurtec (also received top honors in the…
Read Now
